Sponsor
Omeros Ireland Limited
Ormond Building, 31-36 Ormond Quay Upper, D07 EE37 Dublin, Ireland
About the sponsor
Clinical research activity is centered on paroxysmal nocturnal hemoglobinuria, with attention to the management of complement-mediated hemolysis and related disease burden in patients with an incomplete response to existing C5 inhibitor therapy.
- Paroxysmal nocturnal hemoglobinuria
- Complement system inhibition
- Hemolytic anemia
The sponsor’s trial portfolio reflects a focused interest in therapies for rare hematologic disorders, particularly treatment pathways aimed at improving control of intravascular hemolysis and associated clinical symptoms.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.